Concepedia

Author

Bayard Clarkson

Memorial Sloan Kettering Cancer Center

Also Known As

B CLARKSON, B Clarkson, B. Clarkson, BAYARD CLARKSON, Bayard C. Clarkson, Bayard Clarkson, Z Rolović

59

Publications

6.3K

Citations

24

H-Index

72

Concepts

All Affiliations

Memorial Sloan Kettering Cancer CenterKettering UniversityHoward Hughes Medical InstituteRockefeller University
BC

About

Bayard Clarkson is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, cell biology, and tumor biology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

19

2.8K

2

Health Sciences

5

5

420

3

Natural Sciences

5

5

1K

4

Biochemistry

4

4

948

5

Engineering

1

1

19

Bayard Clarkson

×

30

Publications

6.2K

Citations

24

H-Index

YearCitations

Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase

Thomas H. Schindler, William G. Bornmann, Patricia Pellicena,

Science

2000

1.8K

Effect of Granulocyte Colony-Stimulating Factor on Neutropenia and Associated Morbidity Due to Chemotherapy for Transitional-Cell Carcinoma of the Urothelium

Janice Gabrilove, Ann A. Jakubowski, Howard I. Scher,

New England Journal of Medicine

1988

953

Structural Basis for the Autoinhibition of c-Abl Tyrosine Kinase

Bhushan Nagar, Oliver Hantschel, Matthew A. Young,

Cell

2003

867

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

Sizhi Paul Gao, Kevin G. Mark, Kenneth Leslie,

Journal of Clinical Investigation

2007

656

Cyclical edema and shock due to increased capillary permeability

Bayard Clarkson, David Thompson, Melvin Horwith,

The American Journal of Medicine

1960

393

Phase I study of granulocyte colony-stimulating factor in patients with transitional cell carcinoma of the urothelium.

Janice Gabrilove, Ann A. Jakubowski, Katie Fain,

Journal of Clinical Investigation

1988

231

Gleevec inhibits β-amyloid production but not Notch cleavage

William J. Netzer, Fei Dou, Dongming Cai,

Proceedings of the National Academy of Sciences

2003

195

Effects of Human Granulocyte Colony-Stimulating Factor in a Patient with Idiopathic Neutropenia

Ann A. Jakubowski, L. M. Souza, Felecia Kelly,

New England Journal of Medicine

1989

159

Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance

Mohammad Azam, Valentina Nardi, William C. Shakespeare,

Proceedings of the National Academy of Sciences

2006

108

18q21 rearrangement in diffuse large cell lymphoma: incidence and clinical significance

Kenneth Offit, Prasad Koduru, Rachel Hollis,

British Journal of Haematology

1989

100

Page 1